Eliquis was North Carolina's costliest Medicare Part D drug in 2023 at $689 million, about 1.7 times the next-highest drug. Medicare's negotiated price took effect in 2026. Here is what changed.
One drug. Ranked 12th in prescriptions. But in 2023 it cost about 1.7 times as much as North Carolina's second most expensive Medicare drug.
Apixaban (brand name Eliquis) is a blood thinner prescribed mainly to reduce stroke risk in people with atrial fibrillation. AFib becomes more common with age, causing the heart's upper chambers to beat irregularly. Blood can pool and form clots that travel to the brain and cause a stroke. Apixaban disrupts that process. A large and growing Medicare population drives significant Apixaban volume in North Carolina.
Warfarin, the original blood thinner, costs about $14 per prescription. Apixaban cost an average of $834 in 2023. Apixaban requires no regular blood monitoring, while Warfarin requires regular INR tests to keep dosing safe. For patients in rural North Carolina, where a lab can be an hour away, that convenience is a real clinical benefit. Apixaban remains under patent, so no generic exists in the U.S.
Eliquis was one of the first ten drugs chosen for Medicare's price negotiation program under the Inflation Reduction Act. The negotiated price took effect on January 1, 2026: $231 for a 30-day supply, compared with a $521 list price, or about 56% lower. The figures at the top of this article come from 2023 claims, before any negotiated price applied, so they do not reflect the new price.
| Drug | List price (30 days) | Negotiated price from Jan. 1, 2026 | Discount |
|---|---|---|---|
| Eliquis (apixaban) | $521 | $231 | 56% |
| Xarelto | $517 | $197 | 62% |
| Jardiance | $573 | $197 | 66% |
| Farxiga | $556 | $178.50 | 68% |
All four of these drugs are in North Carolina's top ten by 2023 Part D spending (see the chart below). The negotiated price is what Medicare pays, not your copay. Your plan decides your tier and cost sharing, and a lower drug price can lower what you pay when your plan charges a percentage of the cost instead of a flat copay.
Plans place Eliquis on different tiers, so the same drug can cost very different amounts from one plan to the next. Part D now caps what you pay out of pocket for covered drugs: $2,000 in 2025, $2,100 in 2026 and $2,400 in 2027. Once you reach the cap you pay $0 for covered Part D drugs for the rest of the year. The standard deductible rises to $700 in 2027, although many plans charge less. The Medicare Prescription Payment Plan can spread your costs over monthly payments.
North Carolina's rural communities often have fewer plan options during open enrollment. Using Medicare Plan Finder at Medicare.gov to compare plans on your specific drugs is especially important when you are outside a major metro area.
For the bigger 2027 drug-coverage picture, read our guide to Medicare Part D in 2027.
Ask whether the original clinical reason you started Apixaban still applies. Some patients start after a procedure and stay on it longer than needed. For some, Warfarin with monitoring remains clinically appropriate and meaningfully cheaper.
Skyler Abilla is a licensed Medicare agent serving North Carolina and South Carolina. Bring your medication list and we will check each drug against every plan available at your address. Call (843) 284-6815 or book a free call.
Source: CMS Medicare Part D Prescribers by Geography and Drug, 2023 (North Carolina). Negotiated prices: CMS Medicare Drug Price Negotiation Program, initial price applicability year 2026, 30-day supply prices as reported by NBC News (August 2024). Part D 2025 to 2027 cap: CMS; 2027 amount per the CMS CY 2027 Rate Announcement (April 2026).
Tell us a little about you and a licensed Abilla Advisors agent will call you. No cost, no obligation.
We do not offer every plan available in your area. To get information on all of your options, contact Medicare.gov, 1-800-MEDICARE, or your local State Health Insurance Assistance Program (SHIP).
Get personalized Medicare guidance with no cost and no obligation.